HROW Insider Trading
Insider Ownership Percentage: 13.67%
Insider Buying (Last 12 Months): $1,864,011.35
Insider Selling (Last 12 Months): $0.00
Harrow Share Price & Price History
Current Price: $28.08
Price Change: ▲ Price Increase of +0.52 (1.89%)
As of 02/28/2025 05:00 PM ET
Harrow Insider Trading History
Harrow Institutional Trading History
Data available starting January 2016
Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.
Read More on Harrow
Today's Range
Now: $28.08
52 Week Range
Now: $28.08
Volume
200,504 shs
Average Volume
326,777 shs
Market Capitalization
$1.00 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.69
Who are the company insiders with the largest holdings of Harrow?
Who are the major institutional investors of Harrow?
Which institutional investors are selling Harrow stock?
In the last quarter, HROW stock was sold by these institutional investors:
- Private Capital Management LLC
- Nuveen Asset Management LLC
- JPMorgan Chase & Co.
- Invesco Ltd.
- Millennium Management LLC
- Bank of America Corp DE
- Assenagon Asset Management S.A.
- BNP Paribas Financial Markets
Which institutional investors are buying Harrow stock?
In the last quarter, HROW stock was acquired by institutional investors including:
- Braidwell LP
- HAP Trading LLC
- Two Sigma Investments LP
- Neuberger Berman Group LLC
- Squarepoint Ops LLC
- Caption Management LLC
- Jane Street Group LLC
- Trexquant Investment LP
Within the last year, these company insiders have bought Harrow stock:
- Opaleye Management Inc (Major Shareholder)
- Mark L Baum (CEO)
- Martin A Makary (Director)
Learn More investors buying Harrow stock.